ESC Premium Access

Can TAVI patients receive aspirin monotherapy as patients after surgical aortic bioprosthesis implantation? Data from the Polish Registry POL-TAVI.

Congress Presentation

About the speaker

Associate Professor Katarzyna Czerwinska-Jelonkiewicz

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
5 presentations
1 follower

6 more presentations in this session

Long-term outcome of mitral valve repair versus replacement in a large series of patients with infective endocarditis

Speaker: Associate Professor E. Ruttmann-Ulmer (Innsbruck, AT)


Comparison of contemporary risk scores for predicting mortality and morbidity after mitral valve surgery

Speaker: Doctor T. Wang (Cleveland, US)


Performance of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantation

Speaker: Mr G. Martin (Manchester, GB)


Metabolic syndrome affects valve-related adverse events after biological heart valve replacement

Speaker: Doctor E. Angeloni (Rome, IT)


Preservation of arterial pulsatility to prevent acquired von willebrand disease with continuous-flow left ventricular assist device : insights from a pig model

Speaker: Doctor F. Vincent (Lille, FR)


Access the full session

Valve repair and assist devices

Speakers: Associate Professor K. Czerwinska-Jelonkiewicz, Associate Professor E. Ruttmann-Ulmer, Doctor T. Wang, Mr G. Martin, Doctor E. Angeloni...

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb